Insider Selling: Trupanion (NASDAQ:TRUP) Director Sells 10,000 Shares of Company Stock

Key Points

  • Director Howard Rubin sold 10,000 Trupanion shares at an average price of $34.50, totaling $345,000. He retained 193,288 shares after the sale, a 4.92% reduction in his ownership.
  • Trupanion reported quarterly EPS of $0.21, beating the $0.17 consensus estimate, and revenue of $405.59 million, above expectations of $402.53 million.
  • Analysts’ consensus rating is Hold, with an average price target of $40. Recent targets ranged from $32 to $34 among analysts maintaining neutral or hold ratings.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) Director Howard Rubin sold 10,000 shares of Trupanion stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $34.50, for a total transaction of $345,000.00. Following the completion of the transaction, the director owned 193,288 shares of the company's stock, valued at $6,668,436. This represents a 4.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Trupanion Trading Up 1.1%

Shares of TRUP stock opened at $36.55 on Wednesday. The company's fifty day simple moving average is $28.10 and its two-hundred day simple moving average is $26.79. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.74 and a quick ratio of 1.74. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $38.87. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 59.92, a PEG ratio of 1.67 and a beta of 1.27.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, November 5th. The financial services provider reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.04. Trupanion had a return on equity of 6.71% and a net margin of 1.71%. The firm had revenue of $405.59 million for the quarter, compared to the consensus estimate of $402.53 million. During the same quarter in the prior year, the business posted $0.13 earnings per share. As a group, analysts anticipate that Trupanion, Inc. will post 0.68 earnings per share for the current year.

Hedge Funds Weigh In On Trupanion




Hedge funds have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in Trupanion during the 2nd quarter worth approximately $134,774,000. Bank of America Corp DE purchased a new stake in Trupanion in the 2nd quarter worth approximately $14,262,000. Renaissancere Holdings Ltd. bought a new position in Trupanion in the 2nd quarter valued at $6,514,510. Bank of New York Mellon Corp bought a new position in Trupanion in the 2nd quarter valued at $4,631,000. Finally, Kopion Asset Management LLC boosted its holdings in Trupanion by 30.9% in the 2nd quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider's stock valued at $12,955,000 after purchasing an additional 123,308 shares during the period.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Piper Sandler lowered Trupanion from an "overweight" rating to a "neutral" rating and decreased their price objective for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Weiss Ratings raised Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, September 29th. Wall Street Zen raised Trupanion from a "hold" rating to a "buy" rating in a report on Saturday, November 7th. Cantor Fitzgerald raised their target price on Trupanion from $30.00 to $33.00 and gave the stock a "neutral" rating in a research note on Monday, November 9th. Finally, Stifel Nicolaus lifted their target price on Trupanion from $29.00 to $34.00 and gave the company a "hold" rating in a report on Monday, November 9th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Trupanion presently has an average rating of "Hold" and a consensus price target of $40.00.

Check Out Our Latest Stock Analysis on Trupanion

Trupanion Company Profile

(Get Free Report)

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.

Further Reading

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Trupanion?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Trupanion and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles